COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Iaso Biotherapeutics is a clinical-stage Chinese biopharma developing and manufacturing fully human antibody-derived autologous and allogeneic CAR‑T and biologics, using IMARS/phage display, high‑throughput CAR‑T screening, and in‑house vector/manufacturing platforms.
